Bone Biologics has appointed Robert E. Gagnon as a member of its board of directors. Gagnon is currently the CFO of clinical stage company Remix Therapeutics. Gagnon has more than 20 years of experience in finance and business operations in the life sciences sector. His experience includes roles as Chief Business Officer and Chief Financial Officer at Verastem Oncology, Chief Financial Officer at Harvard Bioscience, and Executive Vice President, Chief Financial Officer, and Treasurer at Clean Harbors. Gagnon holds an MBA from the MIT Sloan School of Management and a BA in Accounting from Bentley College.